1 to 3 of 3 Results
Feb 28, 2024
Swail, Hanna; Murphy, Tanya; Buckeridge, David, 2023, "SARS-CoV-2 Seroprevalence in Canada", https://doi.org/10.5683/SP3/LAEQ5L, Borealis, V13, UNF:6:qBfS7VjtG7WucCO8KFi+FA== [fileUNF]
This dataset contains population level infection-acquired and vaccine-induced seroprevalence estimates stratified by geography (Canada or by province), social determinants and age group. Data were compiled from over 20 research studies collaborating with the CITF. Trends in SARS-... |
Sep 7, 2023
Yau, Kevin; Hladunewich, Michelle, 2023, "Omicron variant Neutralizing Antibodies Following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 Bivalent Vaccination in Patients with End-Stage Kidney Disease", https://doi.org/10.5683/SP3/9XUY6O, Borealis, V1, UNF:6:mnsl27BuWHH29Jn1jW5+gQ== [fileUNF]
This dataset contains serologic data on patients receiving hemodialysis or kidney transplant recipients prior to and 1 month following receipt of either the BNT162b2 (BA.4/BA.5) or mRNA-1273 (BA.1) bivalent COVID-19 vaccine. Neutralization against wild-type SARS-CoV-2, Omicron BA... |
Aug 14, 2023
Murphy, Tanya; Swail, Hanna; Buckeridge, David, 2023, "The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020–2023", https://doi.org/10.5683/SP3/MDYLUK, Borealis, V1, UNF:6:ED3vSkzNNAWyR51Hdi7GSQ== [fileUNF]
This dataset contains population level infection-acquired and vaccine-induced seroprevalence estimates stratified by geography (Canada or by province) and age. Data were compiled from 7 provincial and pan-Canadian research studies collaborating with the CITF, sampling from the ge... |